Sexual behaviours and sexually transmitted infections among MSM living with HIV followed at a university hospital in Istanbul, Turkey

Creative Commons License

Yağçı Çağlayık D., Doganc F. B., Can R., Ersoy D. M., Soyletir G., Sili U., ...Daha Fazla

International Journal of STD and AIDS, 2025 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1177/09564624251374810
  • Dergi Adı: International Journal of STD and AIDS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Environment Index, Gender Studies Database, MEDLINE, Public Affairs Index
  • Anahtar Kelimeler: Chlamydia (Chlamydia trachomatis) < bacterial disease, gonorrhea (Neisseria gonorrhoeae) < bacterial disease, HIV (Human immunodeficiency virus) < viral disease, screening < other, sexual behaviour < other
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Marmara Üniversitesi Adresli: Evet

Özet

Background: Men sex with men (MSM) are accepted as a hidden key population in the dissemination of HIV in Turkey. Understanding sexual behaviours and Sexually Transmitted Infections (STI) frequency in MSM living with HIV is important to provide appropriate health and control policies. Methods: Sexual anamnesis including 5Ps were taken with triple-site (urine, pharyngeal and rectal swab) screening tests, which were performed according to the recommendations in the HIV follow up guidelines, from 45 MSM living with HIV, who were followed and consecutively attended to their control visit Marmara University Pendik Education and Training Hospital, in Istanbul, in 2018. Results: 24.4 % and 26.7 % of participants tested positive for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG), respectively. This ratio decreased to 6.7% if urine was the only sample taken to be tested. Syphilis seropositivity increased from 18% to 34% during the HIV diagnosis to triple testing time, which is a median period of 28 months. Conclusion: The data obtained emphasizes the screening and reimbursement of triple testing in key population groups.